Form 4: Performant Healthcare Director Awarded Restricted Stock Units

Performant Healthcare Inc. Director Bradley M. Fluegel was granted 35,616 Restricted Stock Units, vesting on the earlier of the 2026 annual meeting or a Change in Control.

Summary

• Bradley M. Fluegel, a Director of Performant Healthcare Inc. (PHLT), was awarded 35,616 Restricted Stock Units (RSUs).
• Each RSU represents a contingent right to receive one share of PHLT's common stock.
• The RSUs were granted at no cost to the reporting person.
• The award vests 100% on the earlier of the Registrant's 2026 annual meeting of stockholders or a Change in Control, as defined in the 2012 Stock Incentive Plan.
• The RSUs will be settled only for shares of common stock on a one-for-one basis.
• The transaction date for this grant is July 28, 2025.

Sentiment

Score: 6

Explanation: The grant of RSUs to a director is a neutral to slightly positive event, indicating continued alignment of interests and standard corporate governance. It's not a major financial event but reflects ongoing compensation practices.

Positives

• Grant of Restricted Stock Units to a director aligns their interests with shareholders, promoting long-term retention and performance.
• The award was granted at no cost to the recipient, representing a direct equity incentive.

Future Outlook

NA

Industry Context

This is a standard equity compensation grant to a director, a common practice across industries to incentivize long-term commitment and align management interests with shareholder value. It does not provide specific insights into Performant Healthcare's competitive position or broader industry trends beyond general corporate governance practices.

Comparison to Industry Standards

• Equity grants to directors, such as Restricted Stock Units, are a common form of compensation in publicly traded companies across various sectors, including healthcare services.
• The specific amount of 35,616 RSUs and the vesting schedule (earlier of annual meeting or change in control) are typical for director compensation plans, aiming to retain talent and align interests.
• Without specific compensation benchmarks for similar-sized healthcare companies or detailed compensation committee reports, a direct comparison to specific comparable companies or projects is not feasible from this Form 4.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential dilution upon vesting and conversion of RSUs into common stock, but also improved alignment of director's interests with shareholder value.

Next Steps

• Vesting of 35,616 Restricted Stock Units on the earlier of the Registrant's 2026 annual meeting of stockholders or a Change in Control.
• Settlement of vested Restricted Stock Units into shares of common stock on a one-for-one basis.

Key Dates

Recommendation

This Form 4 filing details a routine equity compensation grant to a director, which is a standard corporate governance practice. It does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The transaction itself is neutral to slightly positive as it aligns director incentives with shareholder interests, but it's not a catalyst for significant price movement.

Keywords

Performant Healthcare Inc., PHLT, Restricted Stock Units, RSU, Director Compensation, Equity Grant, Form 4, Insider Transaction, Stock Incentive Plan